Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include: Esophagitis, Difficulty swallowing (dysphagia), Increased total eosinophil count, and Vomiting and 2 more.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Digestive system | 3 | Esophagitis, Difficulty swallowing (dysphagia), Vomiting |
Biomarker and diagnostic research for esophagitis, eosinophilic, 2 has been reported in the published literature.
No clinical trials have been registered for esophagitis, eosinophilic, 2.
206 publications have been identified in PubMed for esophagitis, eosinophilic, 2. Research spans Review / Meta-Analysis (48%), Epidemiology / Natural History (17%), and Basic Science / Preclinical (14%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 99 | 48% |
Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 11:11 AM UTC
Online Mendelian Inheritance in Man
1 |
Difficulty swallowing (dysphagia) |
Growth and development | 1 | Failure to thrive |
Disease patterns and progression
35 |
17% |
Laboratory research | 29 | 14% |
Clinical study results | 20 | 10% |
Other research | 8 | 4% |
Patient case studies | 8 | 4% |
Testing and diagnosis research | 5 | 2% |
New treatment approaches | 2 | 1% |
Renzo S (2026). [PMID: 41257441](https://pubmed.ncbi.nlm.nih.gov/41257441/). *J Pediatr Gastroenterol Nutr*. [Epidemiology / Natural History]
Bertin L (2026). [PMID: 41125460](https://pubmed.ncbi.nlm.nih.gov/41125460/). *Dig Liver Dis*. [Review / Meta-Analysis]
Kahan AM (2026). [PMID: 41654171](https://pubmed.ncbi.nlm.nih.gov/41654171/). *J Pediatr Surg*. [Case Report / Case Series]
Batkhurel K (2026). [PMID: 41510895](https://pubmed.ncbi.nlm.nih.gov/41510895/). *J Gastroenterol Hepatol*. [Review / Meta-Analysis]
Farhan K (2026). [PMID: 41497095](https://pubmed.ncbi.nlm.nih.gov/41497095/). *Ann Med Surg (Lond)*. [Review / Meta-Analysis]
Khalaf R (2026). [PMID: 42102009](https://pubmed.ncbi.nlm.nih.gov/42102009/). *Int Arch Allergy Immunol*. [Review / Meta-Analysis]
Bel Imam M (2026). [PMID: 41940247](https://pubmed.ncbi.nlm.nih.gov/41940247/). *Inflamm Intest Dis*. [Review / Meta-Analysis]
Bertin L (2026). [PMID: 41902371](https://pubmed.ncbi.nlm.nih.gov/41902371/). *Eur J Clin Invest*. [Review / Meta-Analysis]
Caldwell JM (2026). [PMID: 41067281](https://pubmed.ncbi.nlm.nih.gov/41067281/). *J Allergy Clin Immunol*. [Clinical Trial Publication]
Schening J (2026). [PMID: 42110121](https://pubmed.ncbi.nlm.nih.gov/42110121/). *JPGN Rep*. [Case Report / Case Series]
AI-curated news mentioning esophagitis, eosinophilic, 2
Updated Aug 27, 2026
AstraZeneca and Amgen achieve a late-stage success for Tezspire in treating esophagitis, paving the way for another FDA submission. This follows the drug's recent expansion into chronic rhinosinusitis, enhancing its therapeutic profile.